Abstract
Solriamfetol (Sunosi) is a dopamine and norepinephrine reuptake inhibitor that was approved in 2019 to manage residual excessive daytime sleepiness in
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have